Caroline Rosseel is a Senior Medical Affairs professional in the EMEA region with Thermo Fisher Scientific, Clinical Sequencing Division. She holds a Master in Pharmaceutical Sciences and a Master in Business Economics from the University of Ghent, Belgium. Caroline is dedicated to advancing precision medicine through clinical evidence generation, supporting clinical research, and enhancing patient-centric approaches by raising awareness for testing. She is the Health Economics and Outcomes Research (HEOR) contact for her team and serves as the vice-chair in the Medtech Europe Cancer Sector Group.